Patient Safety Tool: AHRQ CRE Control and Prevention Toolkit

The Agency for Healthcare Research and Quality has published a toolkit for organizations to use to develop interventions to control carbapenem-resistant Enterobacteriaceae.

Advertisement

Most CRE cases in the United States are caused by Kebsiella pneumoniae carbapenemase, a dangerous, antibiotic-resistant germ. The AHRQ funded leading KPC researchers to develop the toolkit.

Access the toolkit, titled “Carbapenem-Resistant Enterobacteriaceae Control and Prevention Toolkit,” by clicking here.

Note: View our database providing more than 400 reports that link to free downloadable and adaptable tools for use in surgery centers, hospitals and other organizations by clicking here.

More Articles on Infection Control:
Top 10 Infection Control Stories, May 12-16
Certain HAI Mortality Associated With Risk Factors, Not Infection
Sepsis Plays Role in Half of All Hospital Deaths, Study Says

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.